Can Amgen Balance Efficacy, Safety With KRAS/PD-1 Combination?

 
• By Alaric DeArment
  
Amgen presented data for Lumakras at the World Conference on Lung Cancer • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immuno-oncology

More from Anticancer